- All Targets
- Angiogenesis/Tyrosine Kinase
- Cell Cycle/Checkpoint
- HDAC
- Apoptosis
- PARP
- Aurora/Ksp
- MAPK
- PI3K/Akt/mTOR
- Hormone
- Integrase/CCR5
- Proteases/HSP90/HSP70
- Wnt/Hedgehog/Notch
- Jak/Stat
- Ca/cAMP/Lipid Signaling
- Neuro Signaling
- TGF-beta/Smad Signaling
- GPCR
- SCTR
- SSTR
- CRF receptor
- GCGR
- GHSR
- GRF-R
- Ghrelin receptor
- tachykinin NK1 receptor
- vasopressin receptor
- Angiotensin receptor
- CB1 receptor
- CB2 receptor
- OX receptor
- Beta-1 adrenergic receptor
- Smoothened (Smo)
- Alpha-1 receptor
- A2A adenosine receptor
- mGluR2/mGluR3
- PTGFR
- SGLT
- Opioid receptor
- Dopamine receptor
- Beta-2 adrenergic receptor
- Serotonin receptor
- Muscarinic receptor
- Ion channel
- Cytochrome P450
- Others
- Cancer
- Infection
- Endocrinology
- Metabolic Disease
- Inflammation
- Immunology
- Neurological Disease
- Cardiovascular Disease
FTY720(Fingolimod)
(SynonymsFingolimod, Gilenia
)Add to Favor
M.Wt: 343.9
Formula: C19H33NO2.HCl
Solubility: DMSO
Purity: >99%
Storage: at -20℃ 2 years
CAS No.: 162359-56-0
Price and Availability of FTY720(Fingolimod):
Applications & Customer's Feedback of FTY720(Fingolimod):
Pharmacologic evaluation of sulfasalazine, FTY720, and anti-IL-12/23p40 in a TNBS-induced Crohn's disease model.
------ Radi ZA,Heuvelman DM,et al. Dig Dis Sci. 2011 Aug;56:2283-91.
Biological Activity of FTY720(Fingolimod):
FTY720(Fingolimod) is a potent sphingosine-1-phosphate (S1P) receptors agonist with IC50 of 0.137, 10.98 nM for (S)- and (R)- FTY720-phosphate, respectively and reverses the effects of BCR-ABL kinase. It is a novel immunomodulating agent and can sequester lymphocytes in lymph nodes, preventing them from moving to the central nervous system for auto-immune responses in multiple sclerosis and was originally proposed as a anti-rejection medication indicated post-transplantation. [1] It can be phosphorylated by sphingosine kinase and prevents disease in a mouse model of many leukemias caused by BCR-ABL. It does not directly target the BCR-ABL kinase, but instead activates phosphatase 2A (PP2A) which is a tumor suppressor that is inactivated by BCR-ABL. [2] FTY720(Fingolimod) also mediated antitumor effects in hepatocellular carcinoma (HCC) cells by activating PKC . The three HCC cell lines examined, Hep3B, Huh7, and PLC5, exhibited differential susceptibility to FTY720-mediated suppression of cell viability, with IC50 values of 4.5, 6.3, and 11 μM, respectively. [3]
References on FTY720(Fingolimod):
[1] http://en.wikipedia.org/wiki/Fingolimod
[2] Neviani P et al. J Clin Invest. 2007 Sep;117(9):2408-21.
[3] Hung JH et al. Cancer Res. 2008 Feb 15;68(4):1204-12.
Src-bcr-Abl
S1P ReceptorWe give free samples and rewards to people who would like to provide us useful scientific data(western blot, etc.) See Details
Find Multiple Products by Catalog Number
| Dongfeng Chen, The Rausing Lab |
| "Your product U0126(Cat.NO S1102) works well in our experiments. I hope I can get more excellent products from your company in future." |
| R.B. Cambridge |
| "I have used the chemical that I bought from you(Selleck,PTC-124) and it worked well.So we will eventually be ordering more." |
| Zhenghe John Wang Assistant Professor, Case Western Reserve University |
| "We have purchased LBH-589, Saha and MS-275 from you and they all worked well." |
| Jenny Sun |
| "We used the LBH-589 in our experiments. The compound is easy to use with excellent reproducibility." |
| Yu Wang, Harvard University |
| "The GDC0449 compound worked very well. The results in my hands are equally good as what's been published. Thanks for this great resource for our research." |
| Dung-Fang Lee |
| "Based on our preliminary data, I found MLN8237 and VX-680 have good effects in inhibiting Aurka-maintaining ESC self-renewal in mouse ES cells." |
| Jun 2011 Selleck Latest Catalog | ![]() |

